The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...

DUBLIN, CA, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- Through transformative approaches to drug development, ...

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...

Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase of nearly ...

HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane ...

Headwinds in the sector are clearing. That is good news for venture firms seeking liquidity and for a stock market looking ...

April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated ...

EMA states that reduction in animal testing will be gradual. The first qualification opinion for a NAM used in toxicity ...

As Founder, Chairman, and Chief Executive Officer of Royalty Pharma plc since its founding in 1996, Pablo Legorreta stands as one of the most consequential and visionary figures in the intersection of ...